1. Home
  2. TARS vs GEL Comparison

TARS vs GEL Comparison

Compare TARS & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • GEL
  • Stock Information
  • Founded
  • TARS 2016
  • GEL 1996
  • Country
  • TARS United States
  • GEL United States
  • Employees
  • TARS N/A
  • GEL N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • GEL Oil Refining/Marketing
  • Sector
  • TARS Health Care
  • GEL Energy
  • Exchange
  • TARS Nasdaq
  • GEL Nasdaq
  • Market Cap
  • TARS 1.7B
  • GEL 1.6B
  • IPO Year
  • TARS 2020
  • GEL 1996
  • Fundamental
  • Price
  • TARS $40.00
  • GEL $16.72
  • Analyst Decision
  • TARS Strong Buy
  • GEL Buy
  • Analyst Count
  • TARS 7
  • GEL 3
  • Target Price
  • TARS $67.14
  • GEL $18.00
  • AVG Volume (30 Days)
  • TARS 522.7K
  • GEL 392.0K
  • Earning Date
  • TARS 08-11-2025
  • GEL 07-31-2025
  • Dividend Yield
  • TARS N/A
  • GEL 3.98%
  • EPS Growth
  • TARS N/A
  • GEL N/A
  • EPS
  • TARS N/A
  • GEL N/A
  • Revenue
  • TARS $233,674,000.00
  • GEL $2,930,080,000.00
  • Revenue This Year
  • TARS $122.94
  • GEL N/A
  • Revenue Next Year
  • TARS $44.14
  • GEL $5.69
  • P/E Ratio
  • TARS N/A
  • GEL N/A
  • Revenue Growth
  • TARS 449.03
  • GEL 3.87
  • 52 Week Low
  • TARS $20.08
  • GEL $9.86
  • 52 Week High
  • TARS $57.28
  • GEL $17.59
  • Technical
  • Relative Strength Index (RSI)
  • TARS 42.88
  • GEL 51.70
  • Support Level
  • TARS $39.41
  • GEL $16.36
  • Resistance Level
  • TARS $43.33
  • GEL $17.31
  • Average True Range (ATR)
  • TARS 1.67
  • GEL 0.47
  • MACD
  • TARS -0.06
  • GEL -0.11
  • Stochastic Oscillator
  • TARS 13.97
  • GEL 58.47

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

Share on Social Networks: